Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kirsi Laukkanen"'
Autor:
Pilvi Maliniemi, Kirsi Laukkanen, Liisa Väkevä, Katja Dettmer, Tuomas Lipsanen, Leila Jeskanen, Alban Bessede, Peter J. Oefner, Marshall E. Kadin, Annamari Ranki
Publikováno v:
OncoImmunology, Vol 6, Iss 3 (2017)
Indoleamine 2,3-deoxygenase 1 (IDO1) induces immune tolerance in the tumor microenvironment (TME) and is recognized as a potential therapeutic target. We studied the expression of both IDO1 and the related tryptophan 2,3-dioxygenase (TDO) in several
Externí odkaz:
https://doaj.org/article/b1272afb72c74acf83ede93bd1fdc028
Autor:
Maria Kareskoski, Anders Johannisson, Mari Palviainen, Kirsi Laukkanen, Johanna Vakkamäki, Terttu Katila
Matrix metalloproteinase (MMP)-2 and MMP-9 are gelatinases that take part in several reproductive processes. The aim of this study was to measure levels of MMP-2 and MMP-9 in fractionated stallion ejaculates, and to evaluate the association between t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf543258c1419b8f5975f4acca632c43
http://hdl.handle.net/10138/342262
http://hdl.handle.net/10138/342262
Autor:
Kirsi Laukkanen, Seppo Auriola, Mari Palviainen, Annamari Ranki, Pia Siljander, Zeynep Tavukcuoglu, Olli Kärkkäinen, Kati Hanhineva, Vidya Velagapudi
Publikováno v:
Cancers
Volume 12
Issue 11
Volume 12
Issue 11
Simple Summary Cancer changes cell metabolism. In this study, we explored if the metabolic rewiring also alters the metabolite content of cancer-derived extracellular vesicles (EVs). For this, metabolomes of EVs from different cancers (prostate, cuta
Publikováno v:
Journal of Investigative Dermatology. 140:1466-1469.e4
Metabolite profile of extracellular vesicles derived of a cutaneous T-cell lymphoma (CTCL) cell line
Publikováno v:
European Journal of Cancer. 119:S16-S17
Autor:
Liisa Väkevä, Tuomas Lipsanen, Katja Dettmer, Alban Bessede, Pilvi Maliniemi, Kirsi Laukkanen, Peter J. Oefner, Leila Jeskanen, Marshall E. Kadin, Annamari Ranki
Publikováno v:
OncoImmunology, Vol 6, Iss 3 (2017)
Oncoimmunology
Oncoimmunology
Indoleamine 2,3-deoxygenase 1 (IDO1) induces immune tolerance in the tumor microenvironment (TME) and is recognized as a potential therapeutic target. We studied the expression of both IDO1 and the related tryptophan 2,3-dioxygenase (TDO) in several
Publikováno v:
European Journal of Cancer. 101:S10